CME ARTICLE

Abstract

Dr. Gevirtz is Associate Professor of Anesthesiology, Louisiana State University-New Orleans Health Center, and Medical Director, Somnia Pain Management, 627 West Street, Harrison, NY 10528; E-mail: [email protected]. Dr. Gevirtz has disclosed that he has no significant relationships with or financial interests in any commercial organizations pertaining to this educational activity. Dr. Gevirtz also has disclosed that use of botulinum toxin and corticosteroids for treatment of temporomandibular joint pain as discussed in this article has not been approved by the U.S. Food and Drug Administration. All staff members in a position to control the content of this CME activity have disclosed that they have no financial relationships with, or financial interests in, any commercial companies pertaining to this educational activity. Lippincott CME Institute, Inc., has identified and resolved all faculty and staff conflicts of interest regarding this educational activity. Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Lippincott Continuing Medical Education Institute, Inc., designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity expires on September 30, 2010.